Forte Cash Per Share vs Begin Period Cash Flow Analysis
| FBRX Stock | USD 0.62 0.01 0.79% |
Forte Biosciences financial indicator trend analysis is much more than just examining Forte Biosciences latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Forte Biosciences is a good investment. Please check the relationship between Forte Biosciences Cash Per Share and its Begin Period Cash Flow accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Forte Biosciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more information on how to buy Forte Stock please use our How to Invest in Forte Biosciences guide.
Cash Per Share vs Begin Period Cash Flow
Cash Per Share vs Begin Period Cash Flow Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Forte Biosciences Cash Per Share account and Begin Period Cash Flow. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Forte Biosciences' Cash Per Share and Begin Period Cash Flow is -0.47. Overlapping area represents the amount of variation of Cash Per Share that can explain the historical movement of Begin Period Cash Flow in the same time period over historical financial statements of Forte Biosciences, assuming nothing else is changed. The correlation between historical values of Forte Biosciences' Cash Per Share and Begin Period Cash Flow is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cash Per Share of Forte Biosciences are associated (or correlated) with its Begin Period Cash Flow. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Begin Period Cash Flow has no effect on the direction of Cash Per Share i.e., Forte Biosciences' Cash Per Share and Begin Period Cash Flow go up and down completely randomly.
Correlation Coefficient | -0.47 |
| Relationship Direction | Negative |
| Relationship Strength | Very Weak |
Cash Per Share
Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Most indicators from Forte Biosciences' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Forte Biosciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Forte Biosciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more information on how to buy Forte Stock please use our How to Invest in Forte Biosciences guide.Selling General Administrative is likely to drop to about 7.6 M in 2024. Tax Provision is likely to drop to 855.00 in 2024
| 2023 | 2024 (projected) | Depreciation And Amortization | 9K | 8.6K | Interest Income | 1.1M | 1.3M |
Forte Biosciences fundamental ratios Correlations
Click cells to compare fundamentals
Forte Biosciences Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Forte Biosciences fundamental ratios Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 7.7M | 61.2M | 43.3M | 42.0M | 39.0M | 43.2M | |
| Other Current Liab | 343.2K | 1.0M | 812K | 2.0M | 2.2M | 4.0M | |
| Total Current Liabilities | 1.9M | 2.3M | 1.8M | 3.2M | 3.7M | 6.0M | |
| Total Stockholder Equity | (4.8M) | 59.0M | 41.5M | 38.8M | 35.3M | 42.2M | |
| Property Plant And Equipment Net | 4.0M | 150.6K | 97K | 0.0 | 109K | 103.6K | |
| Net Debt | 1.8M | (58.8M) | (42.0M) | (41.1M) | (12.0M) | (12.6M) | |
| Retained Earnings | (5.0M) | (51.5M) | (73.2M) | (87.0M) | (118.5M) | (124.4M) | |
| Accounts Payable | 1.6M | 1.2M | 946K | 1.2M | 1.4M | 1.3M | |
| Cash | 6.9M | 58.8M | 42.0M | 41.1M | 12.0M | 11.4M | |
| Non Current Assets Total | 150.6K | 1.3M | 786K | 486K | 653.0K | 620.3K | |
| Other Assets | 227K | 1.4M | 0.0 | 1.0 | 0.9 | 0.86 | |
| Cash And Short Term Investments | 6.9M | 58.8M | 42.0M | 41.1M | 37.1M | 41.0M | |
| Common Stock Total Equity | 20K | 23K | 1K | 13K | 11.7K | 9.9K | |
| Common Stock Shares Outstanding | 2.1M | 7.4M | 14.0M | 17.4M | 31.6M | 33.1M | |
| Short Term Investments | 52.8M | 55.3M | 12.8M | 25.2M | 22.6M | 29.7M | |
| Liabilities And Stockholders Equity | 7.7M | 61.2M | 43.3M | 42.0M | 39.0M | 43.2M | |
| Non Current Liabilities Total | 28.4M | 10.5M | 1.2M | 946K | 1.2M | 0.0 | |
| Other Current Assets | 53.2K | 76K | 88K | 70K | 1.2M | 672.5K | |
| Other Stockholder Equity | (10.3M) | 110.4M | 114.7M | 125.8M | 153.8M | 105.4M | |
| Total Liab | 12.4M | 2.3M | 1.8M | 3.2M | 3.7M | 3.5M | |
| Property Plant And Equipment Gross | 4.0M | 150.6K | 97K | 0.0 | 118K | 112.1K | |
| Total Current Assets | 7.5M | 59.9M | 42.5M | 41.5M | 38.3M | 41.8M | |
| Accumulated Other Comprehensive Income | 10K | (61.2M) | (43.3M) | 4K | 3.6K | 3.8K | |
| Common Stock | 23K | 1K | 13K | 21K | 36K | 37.8K | |
| Property Plant Equipment | 1.2M | 4.0M | 152K | 97K | 87.3K | 82.9K | |
| Net Tangible Assets | (4.8M) | 59.0M | 41.5M | 38.8M | 44.6M | 29.4M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Forte Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Forte Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Forte Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Forte Biosciences Stock:Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Forte Biosciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more information on how to buy Forte Stock please use our How to Invest in Forte Biosciences guide.You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Complementary Tools for Forte Stock analysis
When running Forte Biosciences' price analysis, check to measure Forte Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Forte Biosciences is operating at the current time. Most of Forte Biosciences' value examination focuses on studying past and present price action to predict the probability of Forte Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Forte Biosciences' price. Additionally, you may evaluate how the addition of Forte Biosciences to your portfolios can decrease your overall portfolio volatility.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |
Is Forte Biosciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Forte Biosciences. If investors know Forte will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Forte Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.91) | Return On Assets (0.61) | Return On Equity (1.04) |
The market value of Forte Biosciences is measured differently than its book value, which is the value of Forte that is recorded on the company's balance sheet. Investors also form their own opinion of Forte Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Forte Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Forte Biosciences' market value can be influenced by many factors that don't directly affect Forte Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Forte Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Forte Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Forte Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.